Srdan Verstovsek, MD, PhD, Chief, Section for Myeloproliferative Neoplasms at the University of Texas MD Anderson Cancer Center, Department of Leukemia, discusses identifying and treating different myeloproliferative neoplasms (MPNs).
Srdan Verstovsek, MD, PhD, Chief, Section for Myeloproliferative Neoplasms at the University of Texas MD Anderson Cancer Center, Department of Leukemia, discusses identifying and treating different myeloproliferative neoplasms (MPNs).
CodeBreaK 200 Data Continues to Support Sotorasib vs Docetaxel in KRAS G12C+ NSCLC
June 7th 2023In most key prespecified molecularly defined subsets of patients with pretreated KRAS G12C–mutated non–small cell lung cancer, sotorasib continued to demonstrate consistent benefit vs docetaxel.
Read More
2 Clarke Drive
Cranbury, NJ 08512